Asset Allocation

As of February 28, 2026.
Type % Net
Cash 1.04%
Stock 59.23%
Bond 31.93%
Convertible 0.00%
Preferred 1.66%
Other 6.15%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 91.71%    % Emerging Markets: 0.31%    % Unidentified Markets: 7.97%

Americas 84.32%
84.24%
Canada 57.88%
United States 26.36%
0.07%
As of February 28, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 5.89%
United Kingdom 3.11%
2.77%
Denmark 0.16%
France 0.68%
Germany 0.81%
Netherlands 0.38%
Switzerland 0.43%
0.00%
0.00%
Greater Asia 1.82%
Japan 0.51%
0.06%
Australia 0.06%
1.06%
Hong Kong 0.22%
Singapore 0.04%
South Korea 0.61%
0.19%
China 0.19%
Unidentified Region 7.97%

Bond Credit Quality Exposure

AAA 14.53%
AA 5.37%
A 7.07%
BBB 20.31%
BB 31.49%
B 10.12%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.16%
Not Available 10.93%
Short Term 0.00%
As of February 28, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
44.22%
Materials
13.44%
Consumer Discretionary
4.04%
Financials
24.87%
Real Estate
1.87%
Sensitive
38.14%
Communication Services
3.90%
Energy
10.41%
Industrials
12.36%
Information Technology
11.48%
Defensive
6.99%
Consumer Staples
2.15%
Health Care
2.83%
Utilities
2.01%
Not Classified
10.65%
Non Classified Equity
2.90%
Not Classified - Non Equity
7.75%
As of February 28, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of February 28, 2026
Type % Net
Government 9.47%
Corporate 69.75%
Securitized 1.21%
Municipal 7.72%
Other 11.85%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.63%
Less than 1 Year
0.63%
Intermediate
66.26%
1 to 3 Years
5.19%
3 to 5 Years
21.62%
5 to 10 Years
39.45%
Long Term
28.02%
10 to 20 Years
7.03%
20 to 30 Years
12.24%
Over 30 Years
8.75%
Other
5.10%
As of February 28, 2026
View Bond Maturity Exposure
Start Trial